We have all read this, of course. But do we understand the full scientific and commercial ramifications of this patenting? What I mean is, yes, I understand that ENZC has patents on its having cited the epitopes (binding sites) on these various viruses, so I assume that means their patents show a way (meaning a formula to make a product for a cure) to stop these viruses from replicating as well as morphing into other future strains.
SO this means that IF any other company wants to use our Patents in their formularies (to do what, I'm not sure, since WE would have the Cure in these/ our Patents), they'd have to ask us permission to use these Patents, which would entail licensing rights, I would assume, so they'd have to pay us to use our Patents in their formularies, to do something in the way of curing these diseases.
OR, it means WE are going to be coming out with products to cure these diseases, by way of citing the epitopes on these viruses, which can stop them from replicating and morphing into other strains, and NO OTHER CO is allowed to use this information to make their own product/s to cure the diseases in this manner (i.e., by using our Patents to do so).
In other words, WHAT can we do with this Patent?: "....our [AI portfolio] has allowed us to claim exclusive rights on an international stage covering critical ["conserved"] target sites on numerous human and animal viruses...:
In other words, I'm not sure what these patents, which I know are very valuable, for citing or identifying these epitopes, actually translate into to or would do in real life...i.e., to make our commercial value extremely profitable.
In other words, after identifying these epitopes or binding or "conserved" sites, what do we do with this information? HOW does this help us, or any biopharma co? What exactly is the next step, using this information?
Can anyone please shed light on this?
